Citi Upgrades Anthera Pharma (ANTH) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Anthera Pharma (ANTH) Tops Q1 EPS by 3c
May 11, 2015 5:31 PM EDTAnthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
... More